流感、冠病防治硏究資料

An epidemiological study of the first 56 cases of coronavirus disease 2019 (COVID-19) confirmed in Hong Kong reveals a containment delay of 6.5 days from first symptom……

OBJECTIVES. To investigate the possible benefits and adverse effects of the addition of lopinavir/ritonavir to a standard treatment protocol for the treatment of severe acute respiratory syndrome…….

Now that a novel coronavirus has been well established as the cause of severe acute respiratory syndrome (SARS) it is important to evaluate what we have learned about the antiviral therapy of SARS…….

The dramatic outbreak of severe acute respiratory syndrome (SARS) has led to the use of high-dose intravenous and oral ribavirin in patients affected with this disorder. Ribavirin, a nucleoside analogue with broad antiviral activity…….